Now showing items 1-2 of 2

    • Bernal Sore, Izela; Navarro Márquez, Mario F.; Osorio Fuentealba, César; Díaz Castro, Francisco; Campo, Andrea del; Donoso Barraza, Camila; Porras Espinoza, Omar; Lavandero González, Sergio; Troncoso Cotal, Rodrigo (Elsevier, 2018)
      Mifepristone is the only FDA-approved drug for glycaemia control in patients with Cushing's syndrome and type 2 diabetes. Mifepristone also has beneficial effects in animal models of diabetes and patients with antipsychotic ...
    • Dassonvalle, Jonatan; Díaz Castro, Francisco; Donoso Barraza, Camila; Sepúlveda, Carlos; Pino de la Fuente, Francisco; Pino, Pamela; Espinosa Escalona, Berta; Chiong Lay, Mario; Llanos Silva, Miguel; Troncoso Cotal, Rodrigo (MDPI, 2020)
      Glucocorticoids (GCs) are critical regulators of energy balance. Their deregulation is associated with the development of obesity and metabolic syndrome. However, it is not understood if obesity alters the tissue glucocorticoid ...